Representatives Butterfield and Bilirakis introduced House Resolution 242 celebrating the success of the Orphan Drug Act and calling for continued support of the legislation. Before the legislation there were only 34 FDA approved treatments for a rare disease. Today there are more than 750 and counting. More than 90 percent of rare diseases are still waiting for an FDA approved treatment. Please ask your Congressional representatives to support the resolution.